TY - JOUR
T1 - EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy
AU - Padeletti, Luigi
AU - Arnar, David O.
AU - Boncinelli, Lorenzo
AU - Brachman, Johannes
AU - Camm, John A.
AU - Daubert, Jean Claude
AU - Kassam, Sarah
AU - Deliens, Luc
AU - Glikson, Michael
AU - Hayes, David
AU - Israel, Carsten
AU - Lampert, Rachel
AU - Lobban, Trudie
AU - Raatikainen, Pekka
AU - Siegal, Gil
AU - Vardas, Panos
AU - Kirchhof, Paulus
AU - Becker, Rüdiger
AU - Cosio, Francisco
AU - Loh, Peter
AU - Cobbe, Stuart
AU - Grace, Andrew
AU - Morgan, John
PY - 2010/10
Y1 - 2010/10
N2 - The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS), based on ethical and legal principles, as well as their own clinical, scientific, and technical experience. It is directed to all healthcare professionals who treat patients with implanted ICDs, nearing end of life, in order to improve the patient dying process. This statement is not intended to recommend or promote device deactivation. Rather, the ultimate judgement regarding this procedure must be made by the patient (or in special conditions by his/her legal representative) after careful communication about the deactivation's consequences, respecting his/her autonomy and clarifying that he/she has a legal and ethical right to refuse it. Obviously, the physician asked to deactivate the ICD and the industry representative asked to assist can conscientiously object to and refuse to perform device deactivation.
AB - The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS), based on ethical and legal principles, as well as their own clinical, scientific, and technical experience. It is directed to all healthcare professionals who treat patients with implanted ICDs, nearing end of life, in order to improve the patient dying process. This statement is not intended to recommend or promote device deactivation. Rather, the ultimate judgement regarding this procedure must be made by the patient (or in special conditions by his/her legal representative) after careful communication about the deactivation's consequences, respecting his/her autonomy and clarifying that he/she has a legal and ethical right to refuse it. Obviously, the physician asked to deactivate the ICD and the industry representative asked to assist can conscientiously object to and refuse to perform device deactivation.
KW - CIED management
KW - End of life patients
KW - ICD deactivation
UR - http://www.scopus.com/inward/record.url?scp=77956033085&partnerID=8YFLogxK
U2 - 10.1093/europace/euq275
DO - 10.1093/europace/euq275
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 20675674
AN - SCOPUS:77956033085
VL - 12
SP - 1480
EP - 1489
JO - Europace
JF - Europace
SN - 1099-5129
IS - 10
ER -